Summary
Bryan Sutherland is a senior scientist with 11 years of experience at the intersection of materials science, biomaterials, and pharmaceutical development. He currently leads design and execution of physicochemical characterization, formulation development, and developability assessments for new drug candidates at Merck, translating molecular profiles into actionable development plans with cross-functional partners. His Ph.D. in Materials Science and Engineering from the University of Delaware, along with postdoctoral work at Wyss Institute and UD, centers on advanced hydrogel platforms and photopolymerizable systems to guide vascular networks and cell therapies. Notably, he has built and mentored research teams, including leading a four-person group at UD and coordinating cross-disciplinary efforts from synthesis to biomanufacturing. Based in Boston, he combines experimental rigor with translational insight to de-risk early discovery programs and bridge the gap between basic science and therapeutic development.
11 years of coding experience
7 years of employment as a software developer
Bachelor of Science (B.S.) and Master of Science (M.S.), Materials Science & Engineering, Bachelor of Science (B.S.) and Master of Science (M.S.), Materials Science & Engineering at Drexel University
Doctor of Philosophy (Ph.D.), Materials Science and Engineering, Doctor of Philosophy (Ph.D.), Materials Science and Engineering at University of Delaware
English